论文部分内容阅读
目的观察脑心通的降脂疗效是否能达到治疗目的。方法以两组对比的方法追踪观察12周(84天)观察脑心通的降脂疗效以及合用辛伐他汀后的降脂疗效。结果两组病人临床症状的改善差异无显著意义,血脂有差异而且高密度脂蛋白和低密度脂蛋白差异有显著意义。结论老年患者中患有心脑血管疾病的高脂血症病人合用辛伐他汀治疗4周后可单用脑心通降脂治疗。
Objective To observe whether Naoxintong lipid-lowering treatment can achieve the purpose of treatment. Methods The comparison of two groups was used to observe the lipid-lowering effect of Naoxintong and the lipid-lowering effect after combined with simvastatin for 12 weeks (84 days). Results There was no significant difference in the improvement of clinical symptoms between the two groups. There was a difference in blood lipids and there was significant difference between HDL and LDL. Conclusion Elderly patients with cardiovascular and cerebrovascular disease in patients with hyperlipidemia combined with simvastatin 4 weeks after treatment with Naoxintongzhi lipid-lowering therapy alone.